SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is experiencing substantial upward momentum, driven by record-breaking inflows into its spot ETFs, signaling robust institutional interest and increasing demand. The community is actively discussing a potential decoupling from Bitcoin's price action and an emerging narrative of a supply squeeze due to decreasing exchange holdings. This has fueled widespread bullish sentiment and anticipation of continued market adoption.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is a focal point of discussion as the competitive landscape for obesity treatments heats up, driven by the recent introduction of Novo Nordisk's oral GLP-1 and its aggressive pricing. Community sentiment is sharply divided between those who believe Viking's pipeline assets, including its oral formulation, remain highly competitive in a vast market, and others who express concern about management's M&A strategy given the evolving competitive pressures. Amidst this, speculation about potential strategic partnerships or acquisitions continues to circulate widely.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus (MNTS) is trending following news of developing a 3D-printed fuel tank for its Vigoride-7 Orbital Service Vehicle, positioning it as an innovator in the burgeoning space sector. Community sentiment is mixed, with some anticipating a significant short squeeze due to high short interest and low float, while others express concern over a recent private placement and potential dilution impacting shareholder value.

Aeva Technologies, Inc. develops sensing paradigm for autonomous vehicles and robotics. The firm offers drones, robotics, vehicle technology, and virtual and augmented reality products. The company was founded by Soroush Salehian Dardashti and Mina Rezk in 2017 and is headquartered in Mountain View, CA.

Aeva Technologies Inc

Aeva Technologies is experiencing significant upward momentum following its announcement of 4D LiDAR integration within the NVIDIA DRIVE Hyperion platform ecosystem. This major collaboration has ignited widespread excitement within the community, with many anticipating a substantial short squeeze and sustained bullish movement. Investors are closely monitoring AEVA's potential as a key player in the evolving LiDAR and autonomous vehicle sector, amplified by its association with NVIDIA.

What is the project about? Vara Network is a substrate-based future proof smart contract platform that is fast, scalable, and makes it simple to create and deploy next-generation Web3.0 dApps Vara is the first standalone network in the Gear Protocol  Gear is a next-gen cloud infrastructure platform providing most intuitive and frictionless environment for web2 and web3 developers to build complex infrastructure solutions and disruptive dApps for any ecosystem  What makes your project unique? Vara is built upon three core concepts: The actor model, and persistent memory — two widely adopted primitives from massive computation and microservices architecture spaces  Wasm — a WebAssembly-based virtual machine that runs on all modern browsers. Proven to be faster than any alternative web2 virtual machines  Vara was created to serve as a wasm-native hub for innovative protocols that leverage parallel execution and asynchronous programming to deliver leading decentralized products in any segment  History of your project. Gear Protocol and the Vara Network were originally created by Nikolay Volf, one of the core developers of Polkadot. In 2021, he embarked on building an advanced layer 1 smart contract platform using Substrate, Polkadot's custom framework. His vision included creating a platform that enables fast and efficient execution of robust, feature-rich dApps while in a seamless development environment similar to that of Web 2.0 development. He did this by  harnessing the power of innovative technologies like Wasm, the Actor Model, and Persistent Memory. These technologies significantly enhance smart contract development and provide a seamless end-user experience and provide the foundation for the development of Vara Network.  1. Q2 2021 - Pre-Seed Round: In the second quarter of 2021, the Protocol secured its initial funding through a pre-seed round. This likely involved seeking investment from early-stage investors or venture capitalists to kickstart the development of the project.  2. Q4 2021 - Seed Round: In December 2021 raised $12 Million in Venture Round. Private investment round led by Blockchange Venture. In addition to Blockchange, other top venture capital funds participated in this round, including Three  Arrows Capital, Lemniscap, Distributed Global, LAO, Mechanism Capital, Bitscale, Spartan Group LLC, HashKey, DI Ventures, Elysium Venture Capital, Signum Capital and P2P Economy lead by Konstantin Lomashuk, along with a number of top executives of Web3 Foundation and Parity Technologies. Dr. Gavin Wood, Founder and ex-CEO of Parity Technologies and one of the key individual investors participating in this round.  3. 2022 - Intensive Scaling and Development, First Test Integrations: Throughout the year 2022, Vara was focused on two primary activities. First, the engagement in an extensive outreach process to build up the team. Second, the project advanced its technical development efforts and started working on integrating their technology with various test environments to ensure its functionality and viability.  4. Q4 2022 - Testnet Launch.   5. Q1 2023 - PoA Launch: In the first quarter of 2023, Vara achieved launch of its Proof of Authority (PoA) consensus network, which is a chain candidate for mainnet.  Current Status of Vara:  Presently, the project boasts a talented and diverse decentralized workforce, consisting of dozens of engineers and other community members  to drive the project's success.  One of the remarkable aspects of Vara is its substantial pipeline of initiatives with over 40 projects.  What’s next for your project? Current projects being researched and developed by the community:  - Intensive testing and improvement of the actor model features in the blockchain space  - Launch of the key stack of dApps in our parallel and asynchronous environment   - Development of innovative infrastructure solutions (e.g offchain zk actors including machine learning) independently and together with the segment leaders  What can your token be used for? VARA tokens maintain core utility features required for the network to operate: transaction fees staking and network security governance other: gas pools for gas reservation  Contributors to the Gear protocol are exploring the mechanics of how to distribute a portion of block rewards directly toward dApp developers

Vara Network

Vara Network is currently trending with heightened community interest, driven by recent listings on new exchanges like MEXC and BitMart, alongside a significant increase in trading volume. Discussions are vibrant around its utility as a Layer 1 network, featuring an AI-integrated exchange and cross-chain bridging technology, leading many to anticipate substantial gains within the broader crypto market, while also noting continued debate over its tokenomics and perceived undervaluation.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

Zeta Global is trending following its strategic collaboration with OpenAI, integrating advanced AI models into its Athena marketing platform. This news has sparked active community debate, with many expecting significant growth and seeing the stock as undervalued, though some remain cautious about similar industry AI integrations and upcoming events.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending on heightened anticipation for the January 7th Congressional hearing, "American Energy Dominance: Dawn of the New Nuclear Era," and a crucial Department of Energy announcement regarding surplus plutonium allocation. The community widely expects Oklo to secure this vital fuel for its Aurora reactors, a move seen as essential for accelerating its role in powering AI data centers and achieving commercialization, especially given the current Energy Secretary's past involvement with the company. Significant bullish sentiment, unusual options activity, and the potential for a short squeeze are driving active investor discussion and positioning, despite some pre-revenue skepticism.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin (WEEDCOIN) is trending with its community enthusiastically pushing the "Green Wave" narrative, driven by discussions around federal cannabis reclassification and its potential impact on the sector. Positioned as a key liquidity driver within the Solana ecosystem, holders emphasize its role in advocating for biological sovereignty and natural medicine against traditional monopolies, likening it to a "Bitcoin, but way higher" for the culture.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending following Nvidia's announcement of an open-source autonomous driving platform and 2027 robotaxi plans, which has fueled significant community debate about its competitive moat. Amidst a recent "Sell" rating from UBS and ongoing concerns about declining EV sales, many are questioning Tesla's financial health and market leadership, while some bulls still anticipate a rebound despite increasing competitive pressures.

Churchill Capital Corp. X is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded by Michael Klein on January 4, 2024 and is headquartered in New York, NY.

Churchill Capital Corp X - Ordinary Shares - Class A

Churchill Capital Corp X 

CCCX is generating significant community buzz, propelled by its recent S-4 filing, upcoming CES presentation, and bullish commentary from Citron Research. Investors anticipate a substantial re-rating for Infleqtion, highlighting its undervalued position in quantum sensing with real-world applications and defense contracts, which could unlock institutional buying post-merger. The sentiment focuses on Infleqtion's lead in deployable quantum technology compared to peers, particularly in national security and GPS-independent navigation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Molina Healthcare, Inc (NYSE:MOH) Receives Consensus Recommendation of "Hold" from Analysts

Molina Healthcare, Inc (NYSE:MOH - Get Free Report) has received a consensus rating of "Hold" from the sixteen research firms that are presently covering the stock, MarketBeat.com reports. Two...

Merit Financial Group LLC Buys 8,721 Shares of Molina Healthcare, Inc $MOH

Merit Financial Group LLC increased its stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 289.3% during the third quarter, according to its most recent filing with the Securities and...

Molina Healthcare, Inc (NYSE:MOH) Short Interest Update

Molina Healthcare, Inc (NYSE:MOH - Get Free Report) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totaling 3,621,816...

Healthcare Stocks To Watch Today - December 31st

UnitedHealth Group, Johnson & Johnson, Hims & Hers Health, Molina Healthcare, Intuitive Surgical, Tempus AI, and Medtronic are the seven Healthcare stocks to watch today, according to MarketBeat's...

Stock Of The Day: Is Molina Healthcare About To Break Out?

Molina Healthcare (MOH) is consolidating at a resistance level. There is a good chance the shares either break out or reverse.read more...

<ul class="summary-bullets"><li>Molina has struggled with slowing revenue growth, stagnant membership, thin margins, and elevated medical costs—particularly in its ACA marketplace business—while facing intense competition from larger managed care rivals.</li><li>Uncertainty around Medicaid and Medicare policy, including potential changes under a Trump administration, continues to weigh on the outlook.</li><li>Most analysts maintain neutral ratings and see limited upside despite improving retail sentiment.</li></ul>Molina Healthcare, Inc. (MOH) did not merely have a forgettable year but a torrid one, as it underperformed the broader market and the healthcare sector significantly. However, hedge fund manager Michael Burry — best known for his prescient short positions — recently offered encouraging comments about the health insurer. His assessment should provide a glimmer of hope for investors who chose to stick with&nbsp;<a href="https://stocktwits.com/symbol/MOH">Molina’s stock</a> despite its disappointing run this year.&nbsp;<img src="https://news.stocktwits-cdn.com/MOH_VS_XLY_Vs_SPY_YTD_Returns_png_ce0226c225.webp" alt="MOH VS XLY Vs SPY YTD Returns.png">Source: KoyfinWhat Burry Likes About MolinaScion Asset Management, run by Burry, disclosed in an early November 13F filing for the third quarter a fresh position in Molina, buying 125,000 shares valued at $23.92 million. The hedge fund has since deregistered itself.&nbsp;Later in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/michaeljburry/status/1990609176783938034">post</a> on X in mid-November, the fund manager said he was long on Molina. The stock climbed 3.2% in the very next session following his comments. A month later, he&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/michaeljburry/status/2001328691130061026">posted</a> again, sharing a news story about four Republicans forcing a vote on an extension of Obamacare subsidies. “This may support MOH, but in the long run matters little to the thesis. I, of course, still like the stock,” he said.Now, Burry has shared a full Substack&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://michaeljburry.substack.com/p/molina-healthcare-ghosts-of-geico?selection=9a3f6f8e-a37d-450d-90c1-cebea977e2d0&amp;r=4repfn&amp;utm_medium=ios&amp;triedRedirect=true#:~:text=So%2C%20the%20question%20becomes%2C%20can%20I%20change%20your%20life%20by%20helping%20you%20understand%20an%20insurance%20company%3F%20And%20will%20that%20make%20you%20the%20next%20Warren%20Buffett%3F%20On%20the%20second%20question%2C%20let%E2%80%99s%20not%20be%20ridiculous">post</a> entitled “Molina Healthcare: Ghosts of GEICO Past.” He has likened Molina to the early-stage GEICO investment made by the iconic investor Warren Buffett.<blockquote>“Most investors simply do not understand insurance companies well enough to invest in them. I have spent a few decades looking at them, and I think I have a handle on it.”</blockquote>He suggested Molina is a “special one” in the insurance industry, “like Warren Buffett found in his wildly successful GEICO investment.”&nbsp;Buffett’s GEICO bet is a well-worn investing tale. After buying the auto insurer’s stock as a college student in 1951, his tryst with the insurer continued. Through Berkshire Hathaway, an investment holding company he has been running as CEO for about six decades, he began amassing shares in GEICO in 1976 and then bought it outright in 1996. Buffett is set to step down as CEO on Wednesday. Berkshire’s latest quarterly results show that GEICO generated revenue of $11.26 billion and raked in earnings before income taxes of $1.77 billion. It is among Berkshire's most profitable subsidiaries.&nbsp;Burry has a Buffett connection despite their differing investment ideologies. He says his social-media handle “Cassandra” was given to him by Buffett, referring to the Trojan prophetess whose accurate warnings went unheeded—an apt parallel to his precise prediction of the housing market collapse.In his latest post, Burry argued that GEICO stock, though a “real steal” for Buffett in 1976, was riskier than buying Molina today, Business Insider&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businessinsider.com/big-short-michael-burry-molina-healthcare-insurance-warren-buffett-geico-2025-12">reported</a>. The “Big Short” fame investor said Molina has a better business proposition in many ways. He sees Molina having a clearer path to significant double-digit long-term earnings than Apple.&nbsp;“Maybe Buffett, if he were in his 40s and only just ramping up his insurance investments, would buy it here for a much smaller Berkshire.”Burry also said he would have bought the company if he had had enough billions.<h2 class="st-heading-2">Molina Worth High Praise?</h2>Founded in 1980 by an emergency room physician named Dr. David Molina in Long Beach, California, the company began modestly with a network of primary care clinics. It then became a large managed care organization (MCO) under the government-sponsored Medicaid and Medicare programs, and through the state insurance marketplaces.&nbsp;Molina operates on a national scale, but it is up against larger peers such as UnitedHealth, which had its fair share of woes this year, Humana, Cigna, Centene, and Elevance Health, born out of the merger between Anthem and WellPoint Health in 2004.<h4 class="st-heading-4" style="text-align:center;">Molina Vs Peers (Valuation)</h4><img src="https://news.stocktwits-cdn.com/koyfin_20251231_031833562_png_aaa504dc8f.webp" alt="koyfin_20251231_031833562.png">Source: Koyfin (data as of Dec. 29)About 95% of Molina’s third-quarter revenue came from premiums. For the full year, it expects premium revenue of $42.5 billion. Commenting on the quarterly results, CEO Joseph Zubretsky said:<blockquote>“The headline for the quarter is that approximately half of our underperformance is driven by the Marketplace business, and that Medicaid, while experiencing some pressure, is producing strong margins.”</blockquote>Quarterly revenue has flatlined at around $11 billion, and growth has slowed. The company derives the bulk of its revenue from the Medicare segment (70% of the total Q3 revenue). Membership growth hasn’t changed markedly, remaining between 5 million and 6 million since 2021, and the margin profile isn’t attractive either.&nbsp;<img src="https://news.stocktwits-cdn.com/MOH_Uninspiring_Topline_Trend_1_png_c45849d4d3.webp" alt="MOH_Uninspiring_Topline_Trend (1).png">Source: Fiscal.aiThe third quarter saw a dip in operating margin to 1.2% as higher-than-expected medical cost trends,&nbsp;particularly in the Affordable Care Act marketplace, increased the medical care ratio — a key measure of profitability for an insurer.<img src="https://news.stocktwits-cdn.com/Molinas_Quarterly_Operating_Margin_png_107d0e7b71.webp" alt="Molinas_Quarterly_Operating_Margin.png">Source: Fiscal.ai<h2 class="st-heading-2">Looming Risks</h2>The Trump administration’s evolving healthcare policy poses a significant risk to Molina. The changes in Medicaid and Medicare policy, including eligibility standards, funding allocation and reimbursement frameworks, could weigh down on revenue and longer-term margins. After announcing agreements with drug firms to lower prescription drug prices, the president said he would also meet with insurers to reduce prices.&nbsp;In a note released in early December, Cantor Fitzgerald said CMS Medicaid work requirement guidance, mandated via Trump’s tax bill, suggests a challenging year ahead for Medicaid, the Fly reported. The new CMS guidance dictates how states can plan to implement Medicaid work requirements and some elements of it, including that Payors cannot help determine if a Medicaid beneficiary is complying with work requirements, came as a surprise, the firm said.Jefferies reduced the price target for Molina in a note released in mid-December. The firm maintained a ‘Neutral’ rating. The firm’s price target cut was to account for its expectations of an enhanced Medicaid Medical Loss Ratio (MLR) build and detailed Trump tax law assumptions, resulting in a slight downward adjustment to the valuation.Retail sentiment toward Molina stock on Stocktwits has improved to ‘extremely bullish’ as of early Wednesday. Burry’s Molina comments set off brisk retail chatter, with the 24-hour message volume rising 850%.<figure class="image"><img style="aspect-ratio:725/440;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_31_at_4_03_32_AM_png_fcf6e74188.webp" alt="Screenshot 2025-12-31 at 4.03.32 AM.png" width="725" height="440"></figure>Analysts hold a muted view of the stock, with 12 of the 18 analysts rating it ‘neutral,’ according to Koyin. Two analysts have a ‘Strong Sell’ rating, and four analysts have a ‘Buy’ rating. The average analyst rating for the stock is $176.63, implying merely 3.5% upside from current levels — a not attractive proposition, considering the year’s slump.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/innodata-picks-and-shovels-ai-play-with-80-upside/cL7IcIWREUw">Innodata Emerges As Picks-And-Shovels AI Play Poised For 80% Upside Ahead – And It Is Back On Retail's Radar</a>

In this photo illustration a Molina Healthcare logo seen displayed on a smartphone screen on a desk next to a cafe, a pen, glasses and a magazine in Athens, Greece on June 5, 2022. 

Is Molina Healthcare The Next GEICO? Michael Burry Feels It's A ‘Special One’

The “Big Short” investor has taken a long position in Molina and likened it to an early-stage GEICO, arguing the insurer is undervalued and offers a clearer path to long-term earnings growth than many large-cap peers.

Equity

Molina Healthcare Announces Fourth Quarter and Year-End 2025 Earnings Release and Conference Call Dates

Molina Healthcare, Inc. (NYSE: MOH) today announced it will issue its earnings release for the fourth quarter and year ending December 31, 2025, after the market closes on Thursday, February 5, 2026...

Michael Burry Channels Warren Buffett In Molina Healthcare Stock

Michael Burry published a detailed thesis arguing that Molina is a premier opportunity and compared it to Buffett's move into Geico.read more...

Why Did Molina Healthcare Stock Surge Today?

Key PointsMichael Burry made it public he was investing in Molina Healthcare last month...

Molina Healthcare (NYSE:MOH) Shares Up 3.9% - Here's What Happened

Molina Healthcare (NYSE:MOH) Stock Price Up 3.9% - Time to Buy...

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

Physical AI Infrastructure

Power & Energy to Support Growth

Healthcare Value & Innovation

Other – Comment Below

As markets head into 2026, investors are debating whether the next phase favors speculation or real-world execution. With capital rotating toward infrastructure, energy, and undervalued sectors like healthcare, which area do you think will matter most for portfolios in the year ahead?

Which Theme Will Matter Most for Portfolios in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.34	--	--	N/A
Q3 '25	$3.90	$1.84	-52.87%	MISSED
Q2 '25	$5.62	$5.48	-2.46%	MISSED
Q1 '25	$5.97	$6.08	1.87%	BEAT
Q4 '24	$5.88	$5.05	-14.17%	MISSED

MOH
Molina Healthcare Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MOH News

MOHMolina Healthcare Inc